UNSPSC 51162318: Acetaminophen/dextromethorphan/guaifenesin

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51162318 Acetaminophen/dextromethorphan/guaifenesin is a Commodity code that in practice captures state and local procurement of specialized pharmaceutical products and medical supplies far broader than the code name suggests. Recent opportunities solicited under this code include parenteral nutrition solutions, intravenous products, naloxone, and drug deactivation systems — reflecting state and local governments' need to source clinical pharmaceuticals, emergency medical countermeasures, and related healthcare delivery services for correctional facilities, public health departments, and community health programs. The issuing bodies are state departments (primarily corrections and health agencies) and county governments, each with multiyear contract terms and strict delivery and quality-assurance requirements. State departments of corrections appear as primary buyers, with county public health authorities also active in the code space.

Washington State Department of Corrections issued RFQ RFQQK13020 on September 8, 2026, seeking parenteral products, services, and equipment (parenteral nutrition, IV solutions, and controlled substances) for eight correctional facilities across three regions (West, Central, and East), with bids due October 7, 2026; DOC anticipated selecting up to three bidders per region for an initial term running November 26, 2026 through June 30, 2030, with pricing fixed for two years. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, requesting 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Recent activity concentrates in Washington and Florida, with Washington's correctional system and Florida's county public health infrastructure driving the largest recent solicitations. Both opportunities required E-Verify compliance, commercial general liability insurance, and demonstrated experience in pharmaceutical supply, delivery, and patient-monitoring or community health support.